Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
42 Leser
Artikel bewerten:
(0)

Global Pharmaceutical Membrane Market Report 2015-2019 with EMD Millipore, GEA Filtration, GE Healthcare, Koch Membrane Systems, Sartorius & Spectrum Laboratories Dominating

DUBLIN, Oct. 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2gtkhx/global_membrane) has announced the addition of the "Global Membrane Market in Pharmaceutical Industry 2015-2019" report to their offering.

The global membrane market in pharmaceutical industry to grow at a CAGR of 12.46%, in terms of revenue, during 2014-2019.

The report includes the present scenario and the growth prospects of the global membrane market in pharmaceutical industry for the period 2015-2019. The market can be segmented into two divisions: Technology and applications. The report covers the Americas, APAC, and EMEA markets and also includes the key vendors operating in the market.

Membranes are increasingly becoming an integral part of many pharmaceutical manufacturing processes and water management systems. Various developments in membrane technology and materials such as perfluoropolymer, solid polymer electrolyte, nonporous nanofiltration and fouling-resistant multilayer membranes will positively affect the growth of the market. Also the increase in market competition is forcing vendors to increase their focus on R&D to provide high-quality and technically advanced membrane systems with additional control features that can be easily maintained by end-users throughout their life cycle. However, prices of certain products needed to carry out the research are high, making it difficult for manufacturers to manage their R&D costs.

According to the report, the pharmaceutical industry involves the production, development, and marketing of medications. The industry is growing rapidly with the increasing need for and complexity of medication. The aging population, changing lifestyles, and increased chronic diseases are some of the major factors which have increased the demand for pharmaceuticals and led to the growth of this industry. Apart from this, robust economic growth, greater marketing penetration into extra-urban and rural areas, epidemiological changes, continuing rapid expansion of the private hospital sector, and increased government spending on improvements in healthcare infrastructure and spending are also driving the growth of the industry.

Further, the report states that the process of setting up new production facilities for the manufacture of membrane requires high investment.

Key Vendors

  • EMD Millipore
  • GEA Filtration
  • GE Healthcare
  • Koch Membrane Systems
  • Sartorius
  • Spectrum Laboratories

Other Prominent Vendors

  • Applied Membrane Tech
  • Veolia Water Technologies
  • Pall Corporation
  • Graver Technologies
  • TAMI Industries

For more information visit http://www.researchandmarkets.com/research/2gtkhx/global_membrane

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.